ClinicalTrials.gg
RecruitingNCT06810557Rx SLEEPUpdated Feb 12, 2026

Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care

An interventional study of Optimize Sleep Primary Care (OSPC) and Enhanced Usual Care in Obesity, Childhood, Short Sleep and Obesity Prevention, sponsored by Temple University. Recruiting at 1 site in United States. Open to participants aged 6 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Temple University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
6 Years to 11 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 558 studies in Pediatric Obesity with a site in United States — 72 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.

Planned enrollment
312th of 475
50 · median 95
Started
2025
with 28 others
No phase
423 of 558
50 open now
Primary completion
2026-11
later than 26 of 108 live
Registered
523rd of 558
by date

Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 312th largest by planned enrollment of the 475 interventional ones that give a count, is one of 29 that started in 2025, is one of 423 with no phase, reaches primary completion later than 26 of the 108 other live ones, and was the 523rd registered.

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

72 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:

66 more — sign in →

All 72 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.

This study: 6 Years to 11 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 558 studies in Pediatric Obesity with a site in United States, or all of them as a file.
02

Study summary

The goal of this study is to compare two different approaches to help families with children 6-11 years enhance nighttime sleep: 1) working one-on-one with a nurse to learn effective behavioral strategies to try to improve children's sleep or 2) receiving education on a good night's sleep and its benefits. Participating families will meet with a nurse 6 times or receive 6 educational handouts. Participating families will also complete three assessments (start of the study, 2 months and 6 months) during which study questionnaires will be completed, participating children will wear devices that assess sleep and physical activity, participating families will report on what the child ate on two separate days and will be measured for height and weight.

Read the detailed description

The present study is assessing the feasibility and preliminary effectiveness of a brief behavioral intervention to enhance children's sleep and prevent development of obesity. Fifty short sleeping (\< 9 hours/night) children 6-11 years old who are primarily AA/Black and from lower socioeconomic backgrounds will be enrolled into a 6-month study. Children will be randomly assigned to 1 of 2 conditions: 1) optimize sleep primary care (OSPC; behavioral intervention to enhance sleep duration delivered by a nurse in primary care) or 2) enhanced usual care (EUC; usual care plus sleep education). All children will receive standard pediatric care. Families randomized to OSPC will receive a four-session intervention (two zoom-delivered sessions and two brief phone follow-ups) over the first two months with two additional phone follow-ups during maintenance (months 2-6). Families randomized to EUC will receive sleep education that is delivered at the same points of contact as OSPC sessions. At baseline, end of treatment (2 months), and 6 months, the following will be measured from a Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) perspective: reach (e.g., enrollment), adoption (e.g., pediatric provider engagement), implementation (e.g., session attendance, treatment fidelity), maintenance (e.g., retention), and preliminary effectiveness (e.g., changes in sleep duration (actigraphy), eating behaviors (24-hour dietary recalls), physical activity (accelerometry), and anthropometrics (measured height and weight).

03

Conditions studied

  • Obesity, Childhood
  • Short Sleep
  • Obesity Prevention

Browse trials for

Keywords

  • sleep
  • behavioral intervention
  • primary care
  • obesity prevention
  • child
  • pediatric
04

Who can participate

Ages eligible
6 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient at Temple Pediatrics
  • Child age 6-11 years
  • Child time in bed of less than 9 hours per night on most days per week
  • (BMI) for age and biological sex great than the 10th percentile but less than the 95th percentile
  • Understanding of and ability to complete the protocol
  • Parent age at least 18 years and primary caregiver
  • Willingness to be randomized to either condition

Exclusion criteria

Exclusion Criteria:

  • Diagnosed sleep disorder
  • Medication use or diagnosis of medical or psychiatric condition that may impact sleep or weight status
  • Current or planned treatment for weight control
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Behavioral Sleep Intervention

    Behavioral intervention to enhance school-aged children's sleep

    Behavioral: Optimize Sleep Primary Care (OSPC)

  • Other
    Sleep Education

    Sleep Education

    Other: Enhanced Usual Care

Interventions

  • BehavioralOptimize Sleep Primary Care (OSPC)

    In addition to standard care within Temple University Primary Care (TUPC), two face-to-face zoom sessions and four brief phone follow-ups (two during active treatment and two during maintenance) that focus on using effective behavioral strategies (e.g., goal setting, self-monitoring, positive reinforcement, stimulus control, problem-solving) to enhance children's sleep by approximately one hour/night.

  • OtherEnhanced Usual Care

    In addition to standard care within Temple University Primary Care (TUPC), the provision of six education contacts regarding children's sleep needs and the benefits of getting a good night's sleep.

06

What researchers measure

Primary outcomes

  1. Achievement of enrollment goal

    Primary variable of interest is achievement of a priori goals for study enrollment (i.e., whether 50 families enroll in the study). We will also explore: of children referred, the number who enroll; and of children who are referred and eligible, the number who enroll.

    Time frame: baseline

  2. The number of providers who participate and refer to the intervention

    Of all pediatric providers in the clinic, the number who attend the initial in-service training and the number of referrals each provider makes to the program. Attendance and the number of referrals will be tracked by study staff.

    Time frame: baseline

  3. Average family attendance at intervention sessions

    Whether or not families attend each treatment sessions will be captured by the study nurse. Primary variable of interest is whether families, on average, achieve \> 75% attendance at all intervention sessions.

    Time frame: baseline to 6 months

  4. Nurse percent fidelity/accuracy in delivering the intervention

    All intervention sessions are recorded to determine the accuracy with which nurses deliver the intervention. Specifically, trained staff review recordings and use a checklist to mark whether or not each intervention component is delivered during each session. Primary variable of interest is whether the nurse delivers the intervention with at least 80% fidelity/accuracy.

    Time frame: baseline to 6 months

  5. Percent of families who are retained in the study at both follow-up time points

    Retention at both 2- and 6-months will be tracked by study staff and compared across study arms with a goal of at least 80% retention at two months.

    Time frame: baseline to 6 months

  6. Family assessment of the intervention's acceptability

    Acceptability will be measured by families' responses to the overall acceptability question on the Theoretical Framework for Acceptability (TFA) Acceptability Scale. Specifically, families use a 5-point, likert-type scale ranging from 'completely unacceptable' to 'completely acceptable' to rate the intervention. The percent of families who rate the intervention as 'acceptable' or 'completely acceptable' will be assessed with a goal of at least 80% of families rating it as such.

    Time frame: baseline to 6 months

Secondary outcomes

  1. Preliminary Effectiveness: Sleep

    Measured with actigraphy over 7 days at each assessment and scored with the assistance of sleep diaries and call-ins to time-stamped voicemail. Primary variable of interest is change in the actigraph-estimated sleep period, which is the time between actigraph-estimated bedtime and wake time.

    Time frame: baseline to 6 months

  2. Preliminary Effectiveness: Weight Status

    Child height and weight will be measured by staff to calculate body mass index (BMI). Change in BMI (controlling for child age and biological sex) is of primary interest.

    Time frame: baseline to 6 months

  3. Preliminary Effectiveness: Diet - Caloric Intake

    Measured with 24-hour dietary recalls on two days (one weekday and one weekend day). Mean reported caloric intake will be computed.

    Time frame: baseline to 6 months

  4. Preliminary Effectiveness: Diet - Percent Calories from Fat

    Measured with 24-hour dietary recalls on two days (one weekday and one weekend day). Mean reported percent calories from fat will be computed.

    Time frame: baseline to 6 months

  5. Preliminary Effectiveness: Physical Activity

    Measured with hip-worn accelerometry. Time spent in moderate to vigorous physical activity (controlling for wear time) is of primary interest.

    Time frame: baseline to 6 months

  6. Preliminary Effectiveness: Sedentary Activity

    Measured by parent and child report during 24-hour dietary recalls (one weekday and one weekend day). Mean hours of TV viewing is of primary interest.

    Time frame: baseline to 6 months

07

Study locations

1 of 1 sites recruiting
  • Temple Pediatrics
    Philadelphia, Pennsylvania 19140, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified, cleaned and scored summary data of the following will be shared: parent-completed surveys, child-worn actigraph and accelerometry data, staff-measured parent and child height and weight data, and staff-tracked process data

Supporting information: Study protocol, Informed consent form

Time frame: Data will be made available by the end of the award and will remain available for at least 5 years.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Nov 2026, 18 months after the start.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 18 months is below that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Feb 5, 2025
StartActual
May 15, 2025
Primary completionEst.
Nov 30, 2026
CompletionEst.
Mar 31, 2027
Last update
Feb 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06810557
Lead sponsor
Temple University
Responsible party
Sponsor
First posted
Feb 5, 2025
Start date
May 15, 2025
Primary completion
Nov 30, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Feb 12, 2026

Study contacts

Ashley Ogoe, MPH, CCRP
Contact
ashley.greer@temple.edu
215-707-5782
Chantelle N Hart, PhD
Contact
chantelle.hart@temple.edu
215-707-8639
Chantelle N Hart, PhD
principal investigator · Temple University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion